Bacchus Vascular
U.S. Peripheral Products | Covidien
About Bacchus Vascular
Bacchus Vascular specializes in developing and providing advanced vascular devices designed to improve patient care. Operating in the medical technology sector, the company serves healthcare providers and institutions by offering a range of reliable, safe, and high-quality devices. Bacchus Vascular's business model revolves around the research, development, and commercialization of these medical devices, generating revenue through direct sales to hospitals and clinics. The company aims to address some of the most pressing challenges in healthcare by collaborating with industry experts and leveraging cutting-edge technology. Bacchus Vascular is committed to innovation and quality, ensuring that their products meet the highest standards of safety and efficacy. The company also emphasizes a collaborative and innovative culture, attracting top talent to drive its mission forward.
Source: Dealroom company dataAt a glance
- Founded
- 1999
- Headquarters
- Santa Clara, Cuba
- Sector
- Biotechnology
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Warburg Pincus- DVDeNovo Ventures
The Vertical Group
Kaiser Permanente Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bacchus Vascular on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bacchus Vascular on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.